ADAGE CAPITAL PARTNERS GP, L.L.C. - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q3 2015$4,220,000
-10.3%
500,0000.0%0.01%0.0%
Q2 2015$4,705,000
+1.3%
500,0000.0%0.01%
+9.1%
Q1 2015$4,645,000
-15.9%
500,000
-16.7%
0.01%
-21.4%
Q4 2014$5,524,000
-34.8%
600,000
-36.8%
0.01%
-33.3%
Q3 2014$8,469,000
-5.0%
950,000
-16.1%
0.02%
-8.7%
Q2 2014$8,917,000
-0.6%
1,132,2600.0%0.02%
-4.2%
Q1 2014$8,968,000
+6.9%
1,132,260
-15.0%
0.02%
+9.1%
Q4 2013$8,386,000
+77.2%
1,332,2600.0%0.02%
+57.1%
Q3 2013$4,733,000
+82.2%
1,332,2600.0%0.01%
+75.0%
Q2 2013$2,598,0001,332,2600.01%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,757,260$8,299,0004.68%
Tamarack Advisers, LP 1,825,000$5,493,0003.43%
CLOUGH CAPITAL PARTNERS L P 2,958,415$8,905,0000.56%
AlphaOne Investment Services, LLC 550,712$1,653,0000.42%
Rock Springs Capital Management LP 1,200,000$3,612,0000.21%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,894,948$14,734,0000.13%
KNOTT DAVID M 76,300$230,0000.11%
SABBY MANAGEMENT, LLC 273,010$819,0000.04%
PUTNAM INVESTMENTS LLC 3,438,484$10,315,0000.02%
ARDSLEY ADVISORY PARTNERS LP 40,000$120,0000.02%
View complete list of CARDIOME PHARMA CORP shareholders